Evaluation of Drug Blood-Brain-Barrier Permeability Using a Microfluidic Chip

Area of Science:

• Neuroscience
• Pharmacology
• Biotechnology

Background:

• The blood-brain barrier (BBB) regulates compound passage into the brain, crucial for drug development.
• Existing in vitro models often fail to fully replicate the human BBB's complexity.
• Accurate BBB permeability prediction is vital for efficient drug candidate screening.

Purpose of the Study:

• To develop and validate a predictive model for blood-brain barrier (BBB) permeability using a microfluidic system.
• To assess the utility of the Emulate BBB-on-a-chip machine for estimating compound permeability.
• To establish correlations between physicochemical properties and BBB penetration.

Main Methods:

• Utilized the Emulate BBB-on-a-chip machine with human-derived cells.
• Evaluated the permeability of ten diverse compounds.
• Analyzed and compared permeability data with established animal and cell-based models.
• Correlated partition coefficient (Kp) with apparent permeability (Papp).

Main Results:

• The microfluidic system demonstrated permeability trends consistent with prior animal and cell-based studies.
• The model successfully estimated the BBB permeability of ten evaluated compounds.
• A significant correlation was found between the partition coefficient (Kp) and apparent permeability (Papp).

Conclusions:

• Introduced a novel microfluidic-based paradigm for predicting blood-brain barrier (BBB) permeability.
• The BBB-on-a-chip system provides a more human-relevant in vitro model for drug development.
• This approach enhances the efficiency of preclinical drug screening by reducing reliance on traditional methods.